Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010831

CHIEF OPERATING OFFICER sold 17,500 shares at $25.03 ($438,099)

  • CHIEF OPERATING OFFICER acquired 14,903 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-11 Exercise or conversion : show line 1 in the form 10b5-1 +14,903 $2.48 $36,959 17,500 D
2024-04-11 Sale : show line 2 in the form 10b5-1 −17,500 $25.03 $438,099 0 D
Open-market sales · 17,500 sh · avg $25.03 · $438,099

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −14,903 60,717 D
Loading xslF345X05/form4-04152024_110448.xml…